In describing the current activities and dynamics of this part of the UK one needs to consider not just the immensely exciting growth of the Cambridge Cluster but also how the M11 is shaping up to be a cash flow highway for our high growth life science companies.
A new world-class centre dedicated to food and health research is gathering momentum at Norwich Research Park.
The £1 million regeneration of the site of the former derelict Two Bears Hotel in Great Yarmouth has reached a major milestone.
Cambridge UK technology consultancy Sagentia is considering a £10 million cash return to shareholders following an abortive trawl of potential acquisitions.
Cambridge is to host a biotech summit for life science executives to meet New Jersey Governor Chris Christie on his visit to the UK in early February.
Dr Richard Jennings, a UK pioneer in the field of academic knowledge transfer, is stepping down as deputy director of Cambridge Enterprise, the university’s commercialisation arm, in March.
Smart metering and lighting technology company Cyan has won a £1 million contract in India which analysts believe could be the turning point for the Cambridge UK business.
UK energy powerhouse Centrica has chosen Cambridge-based CRedit360 to provide a software solution for its global environment, health and safety platform.
Cambridge engineering software firm AVEVA has opened new offices in Saudi Arabia.
Abcam, the Cambridge UK life science tools supplier, has agreed to pay $28 million cash for a US company commercialising technology developed at MIT.
US technology giant Apple has completed the formalities for its move into new offices at 90 Hills Road, Cambridge UK.
Hewlett Packard executives tonight find themselves hurled in front of the wheels of a commercial juggernaut after the UK’s Serious Fraud Office threw out the US company’s fraud allegations against Mike Lynch and former Autonomy executives.
The Cambridge medical technology cluster is leading an upsurge of VC investment into UK biotech.
Risk management technology specialist Brady plc has opened up a new world of business from its Cambridge UK heartland.
The relentless rise of Cambridge personalised medicines pioneer Horizon Discovery was re-emphasised today when the company revealed it was sitting on an R & D milestones and product royalties gold mine in a trading update to the UK market.
Conference business has reached a record high in the Cambridge UK technology heartland.
- Price war hits small Cambridge retailers
- Cambridge company advises Obama on cyber security
- Dialight shares hit by chief exec’s illness
- Landowners and telcos at access loggerheads
- Marketing masterclasses hit the airwaves
- £60bn nuclear opportunity for Cambridge manufacturers
- Spring 2016 target for 400 new Cambridge homes
- Deloitte pinpoints technology boom plays
- Expansion of Cambridge Research Park takes shape
- Bristol-Myers Squibb starts cancer trial with F-star technology
- Carter Jonas acquires Januarys in Cambridge property coup
- Disease diagnostic tech secures $2.4m funding
- UroSens wins $3m and targets US with bladder and prostate cancer test
- Kymab works with global cancer leader on new drugs
- Cambridge firm helps French-US push for new HIV vaccines
- Cambridge inkjet startup targets $8 billion market
Page 1 of 185